Madrid

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Lung cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company3 trials

Running trials

• Active, not recruiting

  A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

  NCT02246621· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

  NCT02152631· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

  NCT02675231· Phase 2· Eli Lilly and Company· Source